This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2018 Jul 24;91(4):180-182.

doi: 10.1212/WNL.0000000000005859. Epub 2018 Jul 3.

IgLON5: A case with predominant cerebellar tau deposits and leptomeningeal inflammation

Affiliations

Affiliations

¹ From the Department of Neurology (F.S., J.L., J.R., N.G., O.E.), German Center for Vertigo and Balance Disorders, DSGZ (F.S.), and Department of Nuclear Medicine (M.U., A.R., N.A., M.B.), Ludwig-Maximilians-University; German Center for Neurodegenerative Diseases (J.L.), DZNE, Munich, Germany; and Division of Pharmacology (N.O.), Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Japan. Florian.Schoeberl@med.uni-muenchen.de.
² From the Department of Neurology (F.S., J.L., J.R., N.G., O.E.), German Center for Vertigo and Balance Disorders, DSGZ (F.S.), and Department of Nuclear Medicine (M.U., A.R., N.A., M.B.), Ludwig-Maximilians-University; German Center for Neurodegenerative Diseases (J.L.), DZNE, Munich, Germany; and Division of Pharmacology (N.O.), Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Japan.

PMID: 29970401
DOI: 10.1212/WNL.0000000000005859

Case Reports

IgLON5: A case with predominant cerebellar tau deposits and leptomeningeal inflammation

Florian Schöberl et al. Neurology. 2018.

. 2018 Jul 24;91(4):180-182.

doi: 10.1212/WNL.0000000000005859. Epub 2018 Jul 3.

Affiliations

¹ From the Department of Neurology (F.S., J.L., J.R., N.G., O.E.), German Center for Vertigo and Balance Disorders, DSGZ (F.S.), and Department of Nuclear Medicine (M.U., A.R., N.A., M.B.), Ludwig-Maximilians-University; German Center for Neurodegenerative Diseases (J.L.), DZNE, Munich, Germany; and Division of Pharmacology (N.O.), Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Japan. Florian.Schoeberl@med.uni-muenchen.de.
² From the Department of Neurology (F.S., J.L., J.R., N.G., O.E.), German Center for Vertigo and Balance Disorders, DSGZ (F.S.), and Department of Nuclear Medicine (M.U., A.R., N.A., M.B.), Ludwig-Maximilians-University; German Center for Neurodegenerative Diseases (J.L.), DZNE, Munich, Germany; and Division of Pharmacology (N.O.), Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Japan.

PMID: 29970401
DOI: 10.1212/WNL.0000000000005859

No abstract available

PubMed Disclaimer

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- The YODA Project